Search clinical trials for: Ruxolitinib Phosphate Cream
Total 5259 results
-
Incyte CorporationCompletedA Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic DermatitisAtopic DermatitisUnited States, Canada
-
Tufts Medical CenterCompleted
-
Incyte CorporationInnovaderm ResearchCompleted
-
Incyte CorporationRecruitingPrurigoUnited States, Spain, France, Poland, Germany, Belgium, Netherlands, Argentina, Italy, Canada, Chile, Brazil
-
Incyte CorporationCompletedAtopic DermatitisUnited States
-
Incyte CorporationRecruitingPrurigo NodularisSpain, Korea, Republic of, United States, Poland, Italy, Austria, Germany, Canada, Switzerland, Australia, France, Denmark, Bulgaria
-
Incyte CorporationCompleted
-
Incyte CorporationRecruitingAtopic DermatitisGermany, Poland, United States, Spain, United Kingdom, Italy, Belgium, Canada, Netherlands, Australia, Bulgaria, France, Switzerland, Hungary, Korea, Republic of
-
Incyte CorporationCompletedAtopic DermatitisUnited States, France, Canada, Hungary, Poland, Germany, Italy
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Germany, Spain, Canada, Poland, Czechia, Bulgaria
-
Incyte CorporationTerminatedAlopecia AreataUnited States
-
Incyte CorporationCompletedCutaneous Lichen PlanusUnited States, Canada
-
Incyte CorporationCompletedHidradenitis SuppurativaUnited States, Canada
-
Incyte CorporationCompletedLichen SclerosusUnited States, Canada
-
Incyte CorporationRecruitingPrurigo NodularisUnited States
-
Milton S. Hershey Medical CenterIncyte CorporationRecruitingHidradenitis SuppurativaUnited States
-
Incyte CorporationActive, not recruitingA Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital VitiligoNonsegmental Vitiligo With Genital InvolvementCanada, United States, France
-
Icahn School of Medicine at Mount SinaiIncyte CorporationCompleted
-
Incyte CorporationRecruiting
-
Incyte CorporationCompleted
-
Incyte CorporationCompletedAtopic DermatitisUnited States
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Canada
-
Incyte CorporationCompletedVitiligoUnited States, Canada, Poland, Spain, Germany, Bulgaria, France, Netherlands
-
Memorial Sloan Kettering Cancer CenterIncyte Corporation; Hackensack Meridian HealthCompletedNon-sclerotic Cutaneous Chronic Graft-versus-host DiseaseUnited States
-
Incyte CorporationCompleted
-
Incyte CorporationActive, not recruitingAtopic Dermatitis (AD)Canada, United States, Poland
-
Incyte CorporationCompletedVitiligoUnited States, Canada, France
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Canada
-
Incyte CorporationActive, not recruitingHand EczemaUnited States, Poland, Canada, Germany
-
Incyte CorporationWithdrawnHand EczemaUnited States, Germany, Spain, Czechia, Canada, Poland
-
Incyte CorporationWithdrawnChronic Hand Eczema (CHE)United States, Canada, Spain, Germany, Czechia, Poland, Bulgaria
-
Incyte CorporationCompletedNon-segmental VitiligoUnited States, Spain, Canada, France, Poland, Bulgaria, Germany, Italy
-
Incyte CorporationCompletedNon-segmental VitiligoUnited States, Canada, Italy, France, Germany, Spain, Poland, Bulgaria, Netherlands
-
National Institute of Arthritis and Musculoskeletal...TerminatedGraft Versus Host Disease | JNS Kinase | Topical AdministrationUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Incyte CorporationRecruitingPregnancy Related | Atopic DermatitisUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mature T- and NK-Cell Non-Hodgkin LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Incyte CorporationCompletedPsoriasisUnited States
-
Incyte CorporationCompletedVitiligoUnited States, Canada
-
OHSU Knight Cancer InstituteCompletedChronic Neutrophilic Leukemia | Atypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Untreated Chronic Lymphocytic LeukemiaUnited States
-
First Affiliated Hospital of Zhejiang UniversityXiangya Hospital of Central South University; Second Affiliated Hospital, School... and other collaboratorsRecruitingHematologic Malignancy | Bronchiolitis Obliterans SyndromeChina
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Julie NangiaIncyte Corporation; Translational Breast Cancer Research ConsortiumRecruitingDuctal Carcinoma In Situ | Atypical Ductal Hyperplasia | Atypical Lobular Hyperplasia | Lobular Carcinoma In SituUnited States
-
Incyte CorporationActive, not recruiting
-
Graceway Pharmaceuticals, LLCCompletedGenital WartsUnited States
-
Beijing Friendship HospitalUnknownHemophagocytic LymphohistiocytosisChina
-
University of North Carolina, Chapel HillCompletedLaparoscopic Hysterectomy and/or Laparoscopic SacrocolpopexyUnited States
-
Children's Hospital Medical Center, CincinnatiRecruitingBronchiolitis Obliterans (BO) | Hematopoietic Stem Cell Transplant (HSCT)United States